DSPE-PEG3400-K237 is a PEG compound composed of DSPE and the KDR-targeting peptide (K237). The peptide K237 effectively disrupts interactions between VEGF and KDR receptors, producing significant biological effects such as the inhibition of angiogenesis and tumor growth. DSPE-PEG3400-K237 is applicable in drug delivery.
Target:
Liposome
* VAT and and shipping costs not included. Errors and price changes excepted
